Mesenchymal stem cells (MSCs) are multipotent stem cells with a high capacity for self-renewal. They can develop into specialized cells of the body such as chondrocytes, osteoblasts and adipocytes. MSCs can also differentiate into nerve cells, heart muscle cells, liver cells and endothelial cells. Their easy accessibility, exceptional genomic stability, and their capacity for tissue repair with few immunological and ethical issues make them the favorable cell type for experimental and clinical use. Many trials are underway using these cells to understand and treat osteoarthritis, sepsis, autoimmune diseases, graft versus host disease, Crohn’s disease, multiple sclerosis, systemic lupus erythematosus and systemic sclerosis.
These bone marrow-derived mesenchymal stem cells were isolated from a neonatal (day 0) male dog leg bone. The cells are cultured, passaged for purity, cryopreserved, and delivered frozen. Each vial contains 1 x 106 cells in 1 mL volume. Cells are characterized by flow cytometry for CD90, CD45, and CD34 and are negative for mycoplasma, yeast, fungi, and bacteria. Cells are assured to further culture using the protocol provided by JangoCell.
